Suchergebnisse - "Zhu, Huangkai"

PubPharm (26)

1

Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma

enthalten in: Journal of cellular and molecular medicine | 2024

von Luo, Q. | Li, X. | Meng, Z. | +6

2

Identification of hypoxia‐related gene signatures based on multi‐omics analysis in lung adenocarcinoma

enthalten in: Journal of Cellular and Molecular Medicine | 2024

von Luo, Q. | Li, X. | Meng, Z. | +6

3

Cellular Senescence in Non-Small Cell Lung Cancer

enthalten in: Frontiers in bioscience (Landmark edition) | 2023

von Zhu, H. | Sun, J. | Zhang, C. | +4

4

18F]FDG PET-CT radiomics signature to predict pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer : a multicenter study

enthalten in: European radiology | 2023

von Yang, M. | Li, X. | Cai, C. | +8

5

A novel PIBF1-RET gene fusion identified from a stage IA lung adenocarcinoma : A case report

enthalten in: Medicine | 2023

von Zhao, W. | Sun, J. | Zhu, H. | +1

6

LncRNA RP11‑805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR‑34b‑3p and miR‑139‑5p in lung adenocarcinoma

enthalten in: Oncology reports | 2022

von Zhu, H. | Xu, X. | Zheng, E. | +4

7

Research progress on the relationship between the TOR signaling pathway regulator, epigenetics, and tumor development

enthalten in: Frontiers in genetics | 2022

von Sun, J. | Yang, M. | Zhao, W. | +6

8

A commentary on "Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer : A propensity score matching retrospective cohort study" (Int J Surg 2020; 84: 25-40)

enthalten in: International journal of surgery (London, England) | 2021

von Zhu, H. | Zhao, G.

CommentOn: Int J Surg. 2020 Dec;84:25-40. - PMID 33086147

9

A rare survival case of blunt left ventricular rupture caused by a low-energy pedestrian collision with a stationary forklift : a case report

enthalten in: Annals of translational medicine | 2021

von Zhu, H. | Zhang, C. | Zhao, W. | +3

10

A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years : a case report

enthalten in: Annals of palliative medicine | 2021

von Ni, J. | Yang, L. | Zhu, H. | +9